NCT05564208View on ClinicalTrials.gov

A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

January 14, 2023

Conditions
Healthy Participants
Interventions
DRUG

elafibranor

Oral Tablet

DRUG

elafibranor

Oral Tablet

Trial Locations (1)

35000

BIOTRIAL, Rennes

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY